Literature DB >> 30673921

Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties?

Christian A Koch1,2,3,4,5, Siegfried Krabbe6,7,8, Bernd Hehmke9.   

Abstract

The immune system is closely intertwined with the endocrine system. Many effects of medications used for various clinical endocrine conditions such as the metabolic syndrome, hypercholesterolemia, diabetes mellitus, hypertension, Graves' disease and others also have an impact on the immune system. Some drugs including statins, metformin, angiotensin converting enzyme and proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones are known to have immunomodulatory properties. We here review the literature on this topic and provide some clinical examples including the use of statins in Graves' orbitopathy, rheumatoid arthritis, multiple sclerosis, and adult-onset Still's disease. In that context, we introduce a special immunodiagnostics method developed at the Institute of  Diabetes "Gerhardt Katsch" in Karlsburg, Germany, to not only measure but also monitor immune disease activity.

Entities:  

Keywords:  Autoantigen; Autoimmune; Flow cytometry; Immune; Interleukin 2; Lupus; Metformin; Multiple sclerosis; Orbitopathy; PCSK9; Rheumatoid arthritis; Somatostatin; Statin; Testosterone; Thyroid

Mesh:

Substances:

Year:  2018        PMID: 30673921     DOI: 10.1007/s11154-018-9478-8

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  9 in total

1.  Immunoendocrinology: When (neuro)endocrinology and immunology meet.

Authors:  Christian A Koch; Alessandro Antonelli
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

Review 2.  Nuclear receptors, cholesterol homeostasis and the immune system.

Authors:  Sayyed Hamed Shahoei; Erik R Nelson
Journal:  J Steroid Biochem Mol Biol       Date:  2019-04-16       Impact factor: 4.292

Review 3.  Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease.

Authors:  Vardaan Gupta; Christine L Hammond; Elisa Roztocil; Mithra O Gonzalez; Steven E Feldon; Collynn F Woeller
Journal:  Surv Ophthalmol       Date:  2021-09-04       Impact factor: 6.197

4.  The various faces of hyperthyroidism.

Authors:  Christian A Koch; Roberto Vita; Salvatore Benvenga
Journal:  J Clin Transl Endocrinol       Date:  2020-06-05

5.  Role of Proprotein Convertase Subtilisin/Kexin Type 9 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.

Authors:  Ga Eun Lee; Jinjoo Kim; Jihei Sara Lee; JaeSang Ko; Eun Jig Lee; Jin Sook Yoon
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-08       Impact factor: 5.555

6.  Association of Other Autoimmune Diseases With Thyroid Eye Disease.

Authors:  Mary Kelada; Parizad Avari; Soma Farag; Rashmi Akishar; Rajni Jain; Ahmad Aziz; Claire Feeney; Vassiliki Bravis; Karim Meeran; Vickie Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-05       Impact factor: 5.555

7.  The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Jianguo Chen; Chaoran Huang; Tongtong Zhang; Wuqing Gong; Xiaofeng Deng; Hua Liu; Jinbo Liu; Yuanbiao Guo
Journal:  Reprod Biol Endocrinol       Date:  2021-12-20       Impact factor: 4.982

Review 8.  Thyroid eye disease: From pathogenesis to targeted therapies.

Authors:  Jin Sook Yoon; Don O Kikkawa
Journal:  Taiwan J Ophthalmol       Date:  2022-01-21

9.  Influence of lipid-lowering drugs on inflammation: what is yet to be done?

Authors:  Sabina Ugovšek; Janja Zupan; Andreja Rehberger Likozar; Miran Šebeštjen
Journal:  Arch Med Sci       Date:  2021-03-20       Impact factor: 3.707

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.